BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 29566840)

  • 21. The Case for Real-world Evidence in the Future of Clinical Research on Chronic Myeloid Leukemia.
    Webster J; Smith BD
    Clin Ther; 2019 Feb; 41(2):336-349. PubMed ID: 30709609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Real-World Evidence: Bridging Gaps in Evidence to Guide Payer Decisions.
    Roberts MH; Ferguson GT
    Pharmacoecon Open; 2021 Mar; 5(1):3-11. PubMed ID: 32557235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Real-world data for health technology assessment for reimbursement decisions in Asia: current landscape and a way forward.
    Lou J; Kc S; Toh KY; Dabak S; Adler A; Ahn J; Bayani DBS; Chan K; Choiphel D; Chua B; Genuino AJ; Guerrero AM; Kearney B; Lin LW; Liu Y; Nakamura R; Pearce F; Prinja S; Pwu RF; Shafie AA; Sui B; Suwantika A; Teerawattananon Y; Tunis S; Wu HM; Zalcberg J; Zhao K; Isaranuwatchai W; Wee HL
    Int J Technol Assess Health Care; 2020 Oct; 36(5):474-480. PubMed ID: 32928330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Real-World Evidence to Inform Regulatory Decision Making: A Scoping Review.
    Jansen MS; Dekkers OM; le Cessie S; Hooft L; Gardarsdottir H; de Boer A; Groenwold RHH
    Clin Pharmacol Ther; 2024 Jun; 115(6):1269-1276. PubMed ID: 38390633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of real-world data and evidence for medical devices: a qualitative study of key informant interviews.
    Polisena J; Jayaraman G
    Int J Technol Assess Health Care; 2020 Dec; 36(6):579-584. PubMed ID: 33161916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of Healthcare Claims Data to Generate Real-World Evidence on Patients With Drug-Resistant Epilepsy: Practical Considerations for Research.
    Stamas N; Vincent T; Evans K; Li Q; Danielson V; Lassagne R; Berger A
    J Health Econ Outcomes Res; 2024; 11(1):57-66. PubMed ID: 38425708
    [No Abstract]   [Full Text] [Related]  

  • 27. Use of real-world evidence in regulatory decisions for rare diseases in the United States-Current status and future directions.
    Wu J; Wang C; Toh S; Pisa FE; Bauer L
    Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1213-1218. PubMed ID: 32003065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Awareness, Knowledge, and Utility of RCT Data vs RWE: Results From a Survey of US Cardiologists: Real-world Evidence in Clinical Decision Making.
    Villines TC; Cziraky MJ; Amin AN
    Clin Med Insights Cardiol; 2020; 14():1179546820953410. PubMed ID: 32952404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What types of real-world evidence studies do U.S. commercial health plans cite in their specialty drug coverage decisions?
    Panzer AD; Margaretos NM; Lai RC; Enright DE; Chambers JD
    Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1307-1311. PubMed ID: 32212282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A framework to guide the optimal development and use of real-world evidence for drug coverage and formulary decisions.
    Pearson SD; Dreitlein WB; Towse A; Hampson G; Henshall C
    J Comp Eff Res; 2018 Dec; 7(12):1145-1152. PubMed ID: 30427724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can we use existing guidance to support the development of robust real-world evidence for health technology assessment/payer decision-making?
    Capkun G; Corry S; Dowling O; Asad Zadeh Vosta Kolaei F; Takyar S; Furtado C; Jónsson P; Kleinermans D; Lambert L; Schiel A; Facey K
    Int J Technol Assess Health Care; 2022 Nov; 38(1):e79. PubMed ID: 36321447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Payer perceptions on the use of economic models in oncology decision making.
    Biskupiak J; Oderda G; Brixner D; Burgoyne D; Arondekar B; Niyazov A
    J Manag Care Spec Pharm; 2021 Nov; 27(11):1560-1567. PubMed ID: 34714111
    [No Abstract]   [Full Text] [Related]  

  • 33. The Use of Real-World Evidence and Data in Clinical Research and Postapproval Safety Studies.
    Lamberti MJ; Kubick W; Awatin J; McCormick J; Carroll J; Getz K
    Ther Innov Regul Sci; 2018 Nov; 52(6):778-783. PubMed ID: 29714579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Teaching Real-World Evidence: Protocol for a Systematic Review.
    Lam C; van Velthoven MH; Chaudhury H; Meinert E
    JMIR Res Protoc; 2020 Jan; 9(1):e16941. PubMed ID: 32012110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrating Real-World Evidence in the Regulatory Decision-Making Process: A Systematic Analysis of Experiences in the US, EU, and China Using a Logic Model.
    Li M; Chen S; Lai Y; Liang Z; Wang J; Shi J; Lin H; Yao D; Hu H; Ung COL
    Front Med (Lausanne); 2021; 8():669509. PubMed ID: 34136505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of real-world evidence for healthcare decision-making in the Middle East: practical considerations and future directions.
    Akhras KS; Alsheikh-Ali AA; Kabbani S
    Expert Rev Pharmacoecon Outcomes Res; 2019 Jun; 19(3):245-250. PubMed ID: 30626231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Real-world evidence generation from patients, their caregivers and physicians supporting clinical, regulatory and guideline decisions: an update on Disease Specific Programmes.
    Anderson P; Higgins V; Courcy J; Doslikova K; Davis VA; Karavali M; Piercy J
    Curr Med Res Opin; 2023 Dec; 39(12):1707-1715. PubMed ID: 37933204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Good Practices for Real-World Data Studies of Treatment and/or Comparative Effectiveness: Recommendations from the Joint ISPOR-ISPE Special Task Force on Real-World Evidence in Health Care Decision Making.
    Berger ML; Sox H; Willke RJ; Brixner DL; Eichler HG; Goettsch W; Madigan D; Makady A; Schneeweiss S; Tarricone R; Wang SV; Watkins J; Mullins CD
    Value Health; 2017 Sep; 20(8):1003-1008. PubMed ID: 28964430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Understanding Use of Real-World Data and Real-World Evidence to Support Regulatory Decisions on Medical Product Effectiveness.
    Mahendraratnam N; Mercon K; Gill M; Benzing L; McClellan MB
    Clin Pharmacol Ther; 2022 Jan; 111(1):150-154. PubMed ID: 33891318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Real world evidence (RWE) - a disruptive innovation or the quiet evolution of medical evidence generation?
    Khosla S; White R; Medina J; Ouwens M; Emmas C; Koder T; Male G; Leonard S
    F1000Res; 2018; 7():111. PubMed ID: 30026923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.